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Introduction
‘Guillain-Barre syndrome’ (GBS) is a broad term used to 
describe a collection of  clinical syndromes which manifest 
as acute immune-mediated demyelinating diseases or 
more rarely axonal diseases of  the peripheral nervous 
system. The most commonly recognised form is ‘acute 
inflammatory demyelinating polyradiculoneuropathy’ 
(AIDP), which classically presents as a proximal and 
distal weakness with diminished reflexes, often involving 
the cranial nerves and muscles of  respiration [1]. It is 
a neurological emergency as these patients are at risk 
of  developing respiratory failure; one third will require 
admission to the Intensive Care Unit (ICU) for ventilatory 
support, and mortality rates of  3-10% have been reported 
[2].
Many clinical variants of  Guillain-Barre syndrome have 
been described in the medical literature, and it is increasingly 
recognised that there is a wide spectrum of  disease with 
considerable overlap between different subtypes [3]. This 
case illustrates an interesting and atypical presentation 
of  the condition, and highlights some of  the potential 
challenges in making a correct diagnosis. 
Clinical Presentation
This case concerns a 67 year old retired GP with a history 
of  hypertension and a partial right nephrectomy for 
oncocytoma ten years previously. He described himself  as 
generally being in good health, apart from an episode of  
diarrhoea two weeks earlier which he had attributed to 
laxative use. 
He initially presented to the Emergency Department (ED) 
with a three-hour history of  acute right sided facial droop 
and slurred speech. Clinical examination confirmed mild 
dysarthria and a right sided weakness affecting the facial 
muscles with apparent sparing of  the forehead. There 
were no other clinical findings of  note and CT brain 
demonstrated no evidence of  infarct or haemorrhage, 
although some underlying small vessel disease was 
identified. A mild hyponatraemia (Na 128) was noted, but 
blood results were otherwise unremarkable. A diagnosis 
of  probable stroke or transient ischaemic attack (TIA) 
was made on clinical grounds; the patient was prescribed 
high-dose aspirin and was discharged from the ED with 
an appointment to attend a rapid-access TIA clinic.
In TIA clinic the following day he continued to present with 
dysarthria and facial weakness, although on examination 
it was found that his facial weakness also included the 
forehead. A slight unsteadiness of  gait was also recorded. 
His hypertension remained poorly controlled with a systolic 
blood pressure of  180, but no other cardiovascular risk 
factors were identified. He was diagnosed as having had a 
stroke on the basis of  the persisting neurological deficit; 
an MRI head and carotid doppler scan were requested. 
Antihypertensive medication was increased and he was 
discharged from the clinic with the provision of  daily 
support from the Community Stroke Team.
Over the following eight days there was a progressive 
deterioration in his clinical condition. Community stroke 
nurses raised concerns over his marked dysarthria and 
severely unsteady gait; they found that he was unable to 
walk independently and was having recurrent falls. They 
also described an unusual upwards rolling of  his eyes on 
attempted eye closure. The patient reported increasing 
difficulty in swallowing. These features appeared to 
increase in severity until it was felt that he was no longer 
safe at home. Urgent hospital admission was arranged.
On admission he was found to have bilateral facial 
weakness, with the right side affected more than the 
Figure 1. Non-enhanced CT of the brain demonstrating small 
vessel disease.
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WCC                          7.3
Hb                              152
MCV                          71
Plt                              233
CRP                            5.7
Bil                               23
Alk phos                    113
Total protein            69  
Albumin                    37
ALT                             42
Urea                           3.1
Na                              112
K                                 3.1
Creatinine                 47
eGFR                          >90
Mg                              0.84
Plasma osmolality  235
Urine osmolality     192
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left. He was unable to close either eye or raise 
his eyebrows. There was no nystagmus but an 
upwards and lateral movement of  the eye occurred 
on attempted eye closure (Bell’s phenomenon). 
Power was reduced in all limbs and the patient 
was areflexic except for a very weak left bicep jerk. 
Marked impairment of  co-ordination was noted 
on upper limb examination but was difficult to 
assess in the lower limbs due to weakness. The 
patient showed no sensory deficits to light touch, 
pin prick or proprioception. Gait could not be 
safely assessed as the patient was unable to walk 
without assistance.
Peak flow was assessed at this time and was 
found to be remarkably low, however the patient 
had a respiratory rate of  18/minute and oxygen 
saturations of  98% on room air. The low peak 
flow was attributed to his inability to use his lips to 
form a complete seal around the peak flow meter 
rather than a weakness of  respiratory muscles.
Investigations
Results from admission blood tests are shown in Box 1. 
The most significant result here is a marked hyponatraemia: 
serum sodium concentration had dropped by 16 mmol/l 
in the twelve days since first presentation. 
Brain MRI confirmed the CT findings of  mild small 
vessel disease. Carotid dopplers did not demonstrate any 
significant stenosis.
Differential Diagnosis
A broad differential diagnosis based on the initial 
presentation is given in Box 2.
The initial diagnosis of  stroke was not unreasonable 
on the basis of  the patient’s initial presentation with a 
unilateral facial weakness which appeared to be due to 
an upper motor neuron lesion. Cerebrovascular events 
are relatively common in this age group, and the patient’s 
uncontrolled hypertension was certainly a further risk 
factor. The absence of  any significant CT findings did not 
preclude a cerebrovascular event as ischaemic changes are 
not always evident on these scans.
In light of  the subsequent symptom progression this 
diagnosis became a less convincing explanation for the 
presentation and differential diagnoses had to be explored. 
Haemorrhagic transformation of  an ischaemic stroke 
could have accounted for this gentleman’s deterioration, 
but repeat CT and MRI refuted this.
The other important feature to be considered was 
the significant drop in serum sodium between initial 
presentation and admission; weakness and ataxia are 
recognised complications of  hyponatraemia. The potential 
causes of  his hyponatraemia needed to be investigated 
further.
On re-admission it became evident that the weakness 
was lower rather than upper motor neuron in nature; 
the salient features in this patient were bilateral facial 
weakness, ataxia and areflexia. Our new differential had 
to encompass causes of  an acute onset, progressive lower 
motor neuron disturbance. 
The clinical features and disease progression led 
us to suspect an acute inflammatory demyelinating 
polyradiculopathy. This was supported by the presence 
of  other clinical features: firstly, hyponatraemia is a 
recognised feature of  GBS. Furthermore, the antecedent 
diarrhoeal illness may have been infective rather than 
secondary to laxative use, which raises the suspicion of  
an infective precipitant such as campylobacter. Based on 
the clinical presentation, we suspected that this gentleman 


















Appearance:                                         clear yellow fluid
WBCs:                                                    1 cell per cm3
RBCs:                                                      43 cells per cm3
Protein:                                                  2.36
Glucose:                                                 2.4
Lactate:                                                  2.28
Culture:                                                  no growth
Box 1. Admission investigations Box 2: A broad differential diagnosis 
based on the initial presentation
Box 3. CSF analysis
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Treatment and Progress
The immediate management of  this patient was to carefully 
correct his hyponatraemia by suspending diuretics, 
restricting fluid intake to <800ml/day and supplementing 
sodium orally.  Regular monitoring was initiated including 
ECGs to detect autonomic dysrhythmias, and oxygen 
saturations and peak flow to detect any decline in 
respiratory function. Bowel and bladder function was also 
monitored, and prophylactic enoxaparin was prescribed.
Urgent neurological review agreed that this was likely to be 
GBS, and lumbar puncture was subsequently performed: 
results are displayed in Box 3. This pattern of  results, 
with grossly elevated protein count, supported our clinical 
diagnosis of  GBS.
GBS can be managed definitively either with intravenous 
immunoglobulin (IVIg) or plasma exchange; IVIg is 
preferred for ease of  administration although the two 
treatments have similar efficacy. Limited evidence exists 
on the value of  such definitive management in Miller 
Fisher variants, and on discussion it was felt that IVIg 
was not immediately necessary since the patient was 
stable with unimpaired respiratory function. A plan was 
made to give supportive therapy, continue correcting 
the hyponatraemia, and to have a low threshold for 
administering IVIg if  there was any deterioration. 
GQ1b ganglioside immunoglobulin G antibody titres were 
requested; these were negative. Stool samples were also 
sent for culture but did not yield any significant results.
Further evidence to support the diagnosis might have 
included nerve conduction studies and electromyography, 
which demonstrate demyelination abnormalities, although 
it should be noted that nerve conduction studies are 
often normal in the first few weeks after symptom onset. 
Facilities for testing were not available in our hospital 
and the patient declined transfer to another hospital 
for testing as he wished to concentrate on recovery and 
rehabilitation.
Over the course of  his admission there was a gradual 
but sustained improvement in this patient’s symptoms. 
He became progressively less dysarthric and, with 
physiotherapy input, was able to mobilise safely on the 
ward.
Once serum sodium improvement was shown to be 
sustained, antihypertensive medications were reviewed 
and optimised. After a four week admission he was no 
longer dysarthric, weakness had completely resolved and 
there was only a mild degree of  ataxia. He was discharged 
home, with further input from community physiotherapy 
to further improve mobilisation.
Discussion
Guillain-Barre syndrome has an incidence of  2 per 100 
000. [4] A number of  infective triggers (usually respiratory 
or GI tract) have been identified. Pathophysiologically 
there is is a post infectious immune-mediated process 
caused by production of  autoantibodies which cross react 
with antigens specific to myelin in the peripheral nervous 
system [3].
Clinical presentation is highly variable: weakness can also 
present as ophthalmoplegia, facial weakness, dysphagia 
or respiratory failure. Patients may demonstrate Bell’s 
phenomenon, an upwards and lateral deviation of  the eye 
while attempting eye closure; this phenomenon occurs in 
facial palsy of  any cause.
Loss of  autonomic function can present as orthostatic 
hypotension or cardiac arrhythmias, and sensory loss can 
manifest as complete loss of  deep tendon reflexes. Patients 
are also at risk of  developing severe hyponatraemia due to 
inappropriate secretion of  ADH [5].
Miller Fisher Syndrome is a rare variant of  GBS 
characterised by a triad of  ataxia, areflexia and 
ophthalmoplegia; GQ1b autoantibodies are identified in 
95% of  cases [6].
The diagnosis of  GBS is primarily a clinical one, made on the 
basis of  clinical history and examination [3,4]. CSF analysis 
is used to support the diagnosis, and characteristically 
demonstrates albuminocytologic dissociation, an elevated 
protein count without an associated rise in white cell count; 
this represents widespread inflammation of  the nerve 
roots. Electromyography and nerve conduction studies 
can be valuable in supporting the diagnosis. Although a 
number of  autoantibodies have been identified, serum 
Figure 2. Serum sodium concentration over the course of the 
illness. (normal range 133-146 mmol/L)
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autoantibody testing is not routinely used for diagnosis, 
although it may be of  value in cases where the diagnosis 
is uncertain.
The immediate management of  suspected GBS is urgent 
hospital admission and monitoring of  respiratory function, 
as symptoms can deteriorate rapidly and seemingly well 
patients can quickly develop respiratory failure or have 
cardiac arrhythmias secondary to autonomic dysfunction. 
Approximately a third of  all GBS cases will require ICU 
admission, although stable patients can be managed 
on a general medical ward. Medical management is 
with immunomodulatory therapy [7]: intravenous 
immunoglobulins (IVIg) and plasma exchange have 
been shown to be equally efficacious, although IVIg 
is often preferred due to ease of  implementation [8,9]. 
Once stable, patients with GBS often require extensive 
rehabilitation. To date there have been no specific 
studies on rehabilitation of  GBS, but active rehab with 
physiotherapy is advised on the basis of  experience with 
other neurological conditions [10].
Despite advances in treatment, GBS has a mortality rate 
of  up to 10%. Relapse is uncommon but many patients 
will be left with residual deficits: motor sequelae are 
particularly common, affecting 20%. Persistent fatigue is 
widely reported, and a number of  studies have highlighted 
the longstanding changes in psychosocial function, which 
can be severe but do not not correlate with the severity of  
residual neurological deficits [11].
This case raised a number of  diagnostic challenges. 
One of  the most significant issues was that the initial 
clinical features mimicked those of  a stroke; GBS was 
not considered in the original differential because the 
presentation was atypical. The focus on the presumed 
diagnosis of  stroke meant that suggestive features 
in the patient’s history, such as the recent diarrhoeal 
illness and hyponatraemia, were dismissed as incidental. 
Furthermore, the significance of  early progression with 
forehead involvement and development of  gait instability 
were neglected. 
Sudden onset neurological deficits are a common 
presentation in acute medicine; the most common cause 
in older patients is cardiovascular events. A variety of  
less common conditions can present in similar ways, 
and it is important for clinicians to consider the broader 
differential before reaching conclusions about diagnosis. 
This case highlighted the importance of  a thorough 
neurological exam to discern between upper and lower 
motor neuron symptoms. It also emphasised that symptom 
progression over time should be considered when making 
a neurological diagnosis.
Learning points
Acute neurological deficit is not always a • 
cerebrovascular accident.
Careful history-taking, discerning neurological • 
examination and an understanding of  symptom 
progression are all vital to making accurate neurological 
diagnoses.
Diagnosis of  GBS is supported by an elevated protein • 
count and normal white cell count in the CSF.
Patients with GBS are at risk of  becoming • 
hyponatraemic; serum sodium should be closely 
monitored.
GBS always warrants hospital admission (even when • 
symptoms are mild) because these patients are at 
risk of  rapid deterioration with ventilatory failure 
requiring ICU admission.
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